Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease

Metabolic Brain Disease

Volumn 30, Issue 6, 2015, Pages 1369-1377

  Vergouts, Maxime ^a   Marinangeli, Claudia ^a   Ingelbrecht, Caroline ^a   Genard, Geraldine ^a   Schakman, Olivier ^a   Sternotte, Anthony ^a   Calas, André Guilhem ^a   Hermans, Emmanuel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

AMP kinase; Amyotrophic lateral sclerosis; CatWalk; hSOD1G93A; Locomotor activity; Metabolism

Indexed keywords

ADENYLATE KINASE; COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GAIT; GAIT DISORDER; GENE REPRESSION; LOCOMOTION; MOUSE; NONHUMAN; PROTEIN FUNCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE; WILD TYPE; AGING; ANIMAL; DEFICIENCY; DISEASE COURSE; ENERGY METABOLISM; GAIT DISORDERS, NEUROLOGIC; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PSYCHOLOGY;

ADENYLATE KINASE; AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE PROGRESSION; ENERGY METABOLISM; GAIT DISORDERS, NEUROLOGIC; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; SUPEROXIDE DISMUTASE;

EID: 84947021652     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-015-9706-9     Document Type: Article

References (42)

1. Batka RJ, Brown TJ, Mcmillan KP, Meadows RM, Jones KJ, Haulcomb MM (2014) The need for speed in rodent locomotion analyses. Anat Rec (Hoboken) 297:1839–1864
2. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256:1236–1242
3. Cheng H, Almstrom S, Gimenez-Llort L, Chang R, Ove OS, Hoffer B, Olson L (1997) Gait analysis of adult paraplegic rats after spinal cord repair. Exp Neurol 148:544–557
4. Chiang PM, Ling J, Jeong YH, Price DL, Aja SM, Wong PC (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci U S A 107:16320–16324
5. Chuang CS, Su HL, Cheng FC, Hsu SH, Chuang CF, Liu CS (2010) Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of parkinson’s disease. J Biomed Sci 17:9
6. Coughlan KS, Mitchem MR, Hogg MC, Prehn JH (2015) "Preconditioning" with latrepirdine, an adenosine 5’-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice. Neurobiol Aging 36:1140–1150
7. Dai H, Macarthur L, McAtee M, Hockenbury N, Das P, Bregman BS (2011) Delayed rehabilitation with task-specific therapies improves forelimb function after a cervical spinal cord injury. Restor Neurol Neurosci 29:91–103
8. Deumens R, Jaken RJ, Marcus MA, Joosten EA (2007) The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection. J Neurosci Methods 164:120–130
9. Deumens R, Marinangeli C, Bozkurt A, Brook GA (2014) Assessing motor outcome and functional recovery following nerve injury. Methods Mol Biol 1162:179–188
10. Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, Meininger V (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70:1004–1009
11. Dupuis L, Gonzalez de Aguilar JL, Oudart H, de TM BL, Loeffler JP (2004) Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener Dis 1:245–254
12. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10:75–82
13. Gerber YN, Sabourin JC, Rabano M, Vivanco M, Perrin FE (2012) Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS One 7:e36000
14. Gonzalez de Aguilar JL, Niederhauser-Wiederkehr C, Halter B, de TM DSF, Demougin P, Dupuis L, Primig M, Meininger V, Loeffler JP (2008) Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics 32:207–218
15. Hardie DG, Carling D, Carlson M (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821–855
16. Horman S, Beauloye C, Vanoverschelde JL, Bertrand L (2012) AMP-activated protein kinase in the control of cardiac metabolism and remodeling. Curr Heart Fail Rep 9:164–173
17. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF (2004) Knockout of the alpha2 but not alpha1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279:1070–1079
18. Landree LE, Hanlon AL, Strong DW, Rumbaugh G, Miller IM, Thupari JN, Connolly EC, Huganir RL, Richardson C, Witters LA, Kuhajda FP, Ronnett GV (2004) C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. J Biol Chem 279:3817–3827
19. Lim MA, Selak MA, Xiang Z, Krainc D, Neve RL, Kraemer BC, Watts JL, Kalb RG (2012) Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease. J Neurosci 32:1123–1141
20. Liu YJ, Ju TC, Chen HM, Jang YS, Lee LM, Lai HL, Tai HC, Fang JM, Lin YL, Tu PH, Chern Y (2015a) Activation of AMP-activated protein kinase alpha1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis. Hum Mol Genet 24:787–801
21. Liu YJ, Lee LM, Lai HL, Chern Y (2015b) Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis. FEBS Lett 589:432–439
22. Mancuso R, del VJ, Modol L, Martinez A, Granado-Serrano AB, Ramirez-Nunez O, Pallas M, Portero-Otin M, Osta R, Navarro X (2014) Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics 11:419–432
23. Mancuso R, Olivan S, Osta R, Navarro X (2011) Evolution of gait abnormalities in SOD1(G93A) transgenic mice. Brain Res 1406:65–73
24. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV (2005) Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 280:20493–20502
25. Mead RJ, Bennett EJ, Kennerley AJ, Sharp P, Sunyach C, Kasher P, Berwick J, Pettmann B, Battaglia G, Azzouz M, Grierson A, Shaw PJ (2011) Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS). PLoS One 6:e23244
26. Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ (2001) AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 280:E677–E684
27. Nakano M, Hamada T, Hayashi T, Yonemitsu S, Miyamoto L, Toyoda T, Tanaka S, Masuzaki H, Ebihara K, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y, Otaka A, Fushiki T, Nakao K (2006) alpha2 isoform-specific activation of 5’adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle. Metabolism 55:300–308
28. Niessen HG, Debska-Vielhaber G, Sander K, Angenstein F, Ludolph AC, Hilfert L, Willker W, Leibfritz D, Heinze HJ, Kunz WS, Vielhaber S (2007) Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurol 25:1669–1677
29. Oliveira AS, Pereira RD (2009) Amyotrophic lateral sclerosis (ALS): three letters that change the people’s life. For ever. Arq Neuropsiquiatr 67:750–782
30. Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7:710–723
31. Perera ND, Sheean RK, Scott JW, Kemp BE, Horne MK, Turner BJ (2014) Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models. PLoS One 9:e95549
32. Ramamurthy S, Ronnett GV (2006) Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J Physiol 574:85–93
33. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF (1999) Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 72:1707–1716
34. Vandeputte C, Taymans JM, Casteels C, Coun F, Ni Y, Van LK, Baekelandt V (2010) Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci 11:92
35. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, Mu J, Wojtaszewski JF, Schuit FC, Birnbaum M, Richter E, Burcelin R, Vaulont S (2003a) Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 31:216–219
36. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R, Vaulont S (2003b) The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111:91–98
37. Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, Andreelli F, Foretz M (2009) AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf) 196:81–98
38. Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F (2007) Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabete Metab 33:395–402
39. Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3
40. Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, Seburn KL (2005) Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32:43–50
41. Wuolikainen A, Andersen PM, Moritz T, Marklund SL, Antti H (2012) ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations. Mol Genet Metab 105:472–478
42. Zhao Z, Sui Y, Gao W, Cai B, Fan D (2015) Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. J Int Med Res 43:67–79